Literature DB >> 2246618

ELISA measurement of LDL receptors.

K May1, F B Kraemer, J Chen, A D Cooper.   

Abstract

An enzyme-linked immunosorbent assay was developed for measurement of low density lipoprotein (LDL) receptors. A monospecific polyclonal antibody to LDL receptor purified from rat liver that reacted with rat, mouse, canine, and human LDL receptor was used. With this assay, LDL receptors could be measured on 2-4 x 10(5) adherent cells and 1.0 x 10(5) cells in suspension, although results were more variable with cell suspensions. Membranes from a variety of receptor-rich and receptor-poor tissues could be assayed directly after adherence of the membranes to the ELISA plate by an overnight incubation. In some instances, the quality of the assay was improved by first solubilizing the membranes. The sensitivity of the assay is such that between 0.15 and 2 micrograms of membrane protein is required. This could be obtained from leukocytes in a modest (20-30 ml) quantity of human blood. The assay was used to demonstrate the rapid down-regulation of LDL receptors in human mononuclear leukocytes in response to a cholesterol-containing meal. Overall, the results support the use of ELISA technology to measure LDL receptors, particularly for physiologic studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2246618

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  5 in total

1.  Association between serum soluble low-density lipoprotein receptor levels and metabolic factors in healthy Japanese individuals.

Authors:  Hisashi Shimohiro; Shin-Ichi Taniguchi; Masahiko Koda; Chieko Sakai; Sadako Yamada
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

2.  Low density lipoprotein receptors and polyamine levels in human colorectal adenocarcinoma.

Authors:  M Notarnicola; M Linsalata; M G Caruso; A Cavallini; A Di Leo
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

3.  Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.

Authors:  S Y Choi; L G Fong; M J Kirven; A D Cooper
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

4.  Modulatory role of atorvastatin against high-fat diet and zymosan-induced activation of TLR2/NF-ƙB signaling pathway in C57BL/6 mice.

Authors:  Priyanka Arya; Sayima Nabi; Uma Bhandari
Journal:  Iran J Basic Med Sci       Date:  2021-08       Impact factor: 2.699

5.  Anti-PCSK9 monoclonal antibody attenuates high-fat diet and zymosan-induced vascular inflammation in C57BL/6 mice by modulating TLR2/NF-ƙB signaling pathway.

Authors:  Priyanka Arya; Uma Bhandari; Kalicharan Sharma; Priyanka Bansal
Journal:  Iran J Basic Med Sci       Date:  2022-05       Impact factor: 2.532

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.